|
tbar.gif
Click
here to
submit entries
|
|
|
Merck
& Co., Ranbaxy to Develop Anti-Infective Drugs
|
May 12,
2008--Merck & Co. and Ranbaxy
Laboratories struck an agreement to jointly develop new anti-infective
drugs. Ranbaxy could earn an estimated $100M+ from the collaboration. Bloomberg.com
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
